Cargando…

Establishing Preferred Product Characterization for the Evaluation of RNA Vaccine Antigens

The preferred product characteristics (for chemistry, control, and manufacture), in addition to safety and efficacy, are quintessential requirements for any successful therapeutic. Messenger RNA vaccines constitute a relatively new alternative to traditional vaccine development platforms, and thus t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poveda, Cristina, Biter, Amadeo B., Bottazzi, Maria Elena, Strych, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963847/ https://www.ncbi.nlm.nih.gov/pubmed/31569760 http://dx.doi.org/10.3390/vaccines7040131

Ejemplares similares

Process Characterization and Biophysical Analysis for a Yeast-Expressed Phlebotomus papatasi Salivary Protein (PpSP15) as a Leishmania Vaccine Candidate
por: Chen, Wen-Hsiang, et al.
Publicado: (2020)

Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate
por: Chen, Wen-Hsiang, et al.
Publicado: (2017)

Coronavirus vaccine-associated lung immunopathology-what is the significance?
por: Bottazzi, Maria Elena, et al.
Publicado: (2020)

COVID-19 vaccines: neutralizing antibodies and the alum advantage
por: Hotez, Peter J., et al.
Publicado: (2020)

The SARS-CoV-2 Vaccine Pipeline: an Overview
por: Chen, Wen-Hsiang, et al.
Publicado: (2020)

Heterologous mRNA-protein vaccination with Tc24 induces a robust cellular immune response against Trypanosoma cruzi, characterized by an increased level of polyfunctional CD8(+) T-cells
por: Poveda, Cristina, et al.
Publicado: (2023)

Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen
por: Nyon, Mun Peak, et al.
Publicado: (2018)

The hookworm Ancylostoma ceylanicum intestinal transcriptome provides a platform for selecting drug and vaccine candidates
por: Wei, Junfei, et al.
Publicado: (2016)

The Benefits of Vaccinating With the First Available COVID-19 Coronavirus Vaccine
por: Bartsch, Sarah M., et al.
Publicado: (2021)

DSF Guided Refolding As A Novel Method Of Protein Production
por: Biter, Amadeo B., et al.
Publicado: (2016)

Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention
por: Bartsch, Sarah M., et al.
Publicado: (2020)

Lives and Costs Saved by Expanding and Expediting Coronavirus Disease 2019 Vaccination
por: Bartsch, Sarah M, et al.
Publicado: (2021)

Neglected Tropical Diseases among the Association of Southeast Asian Nations (ASEAN): Overview and Update
por: Hotez, Peter J., et al.
Publicado: (2015)

Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate
por: Chen, Wen-Hsiang, et al.
Publicado: (2021)

Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate
por: Chen, Wen-Hsiang, et al.
Publicado: (2022)

Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With Onchocerca ochengi
por: Zhan, Bin, et al.
Publicado: (2022)

Mucosal Vaccination With Recombinant Tm-WAP49 Protein Induces Protective Humoral and Cellular Immunity Against Experimental Trichuriasis in AKR Mice
por: Wei, Junfei, et al.
Publicado: (2022)

Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain–based vaccine candidate, RBD219-N1C1
por: Lee, Jungsoon, et al.
Publicado: (2021)

Recombinant protein vaccines, a proven approach against coronavirus pandemics
por: Pollet, Jeroen, et al.
Publicado: (2021)

Vaccine Development Against Middle East Respiratory Syndrome
por: Lee, Hai Yen, et al.
Publicado: (2016)

Maintaining face mask use before and after achieving different COVID-19 vaccination coverage levels: a modelling study
por: Bartsch, Sarah M, et al.
Publicado: (2022)

The impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection
por: Nguyen, Duc Minh, et al.
Publicado: (2023)

The impact of vaccine-linked chemotherapy on liver health in a mouse model of chronic Trypanosoma cruzi infection
por: Nguyen, Duc Minh, et al.
Publicado: (2023)

SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice
por: Pollet, Jeroen, et al.
Publicado: (2021)

Protective immunity elicited by the nematode-conserved As37 recombinant protein against Ascaris suum infection
por: Versteeg, Leroy, et al.
Publicado: (2020)

Identification of vaccine targets in pathogens and design of a vaccine using computational approaches
por: Rawal, Kamal, et al.
Publicado: (2021)

Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine
por: Seid, Christopher A, et al.
Publicado: (2015)

A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2
por: Thimmiraju, Syamala Rani, et al.
Publicado: (2023)

Human Schistosomiasis Vaccines as Next Generation Control Tools
por: Hotez, Peter J., et al.
Publicado: (2023)

Facing the challenges of multidrug-resistant Acinetobacter baumannii: progress and prospects in the vaccine development
por: Mat Rahim, NorAziyah, et al.
Publicado: (2021)

Developing a low-cost and accessible COVID-19 vaccine for global health
por: Hotez, Peter J., et al.
Publicado: (2020)

Biochemical and structural characterization of alanine racemase from Bacillus anthracis (Ames)
por: Couñago, Rafael M, et al.
Publicado: (2009)

Discovery and characterization of tumor antigens in hepatocellular carcinoma for mRNA vaccine development
por: Fu, Jiantao, et al.
Publicado: (2022)

A Data-Driven Approach to Construct a Molecular Map of Trypanosoma cruzi to Identify Drugs and Vaccine Targets
por: Nath, Swarsat Kaushik, et al.
Publicado: (2023)

Global regulatory reforms to promote equitable vaccine access in the next pandemic
por: Mahoney, Richard, et al.
Publicado: (2023)

Plants as bioreactors for the production of vaccine antigens
por: Tiwari, Siddharth, et al.
Publicado: (2009)

“Running the Gauntlet”: Formidable challenges in advancing neglected tropical diseases vaccines from development through licensure, and a “Call to Action”
por: Bottazzi, Maria Elena, et al.
Publicado: (2019)

Hierarchical length and sequence preferences establish a single major piRNA 3′-end
por: Stoyko, Daniel, et al.
Publicado: (2022)

COVID-19 vaccine design: the Janus face of immune enhancement
por: Hotez, Peter J., et al.
Publicado: (2020)

Vaccination with pre-diagnostic tumor antigens but not established tumor antigens inhibits spontaneous tumorigenesis in TgMMTV-neu mice
por: Stanton, Sasha E, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1pqr87fehrl2hqkjplgs9m3gjr